Led by chief executive Eric Mayes, 50, this Cambridge company has developed a minimally invasive and radiation-free way for surgeons to locate breast cancer tumours and lymph nodes and remove or biopsy them accurately. It has supported the NHS during the pandemic by offering free magnetic tracer for breast cancer surgeons to allow them to continue treatment away from hospitals, and used its 3D printers to make masks. After developing and commercialising its technology in Europe, sales — which exceeded £9m last year — have been boosted by securing regulatory approval to sell to American hospitals. It has raised close to £17m from investors, including Draper Esprit.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.